Biocryst Pharmaceuticals (BCRX) Retained Earnings (2010 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Retained Earnings came in at -$2.2 billion in Q1 2026, down 25.87% YoY from -$3.0 billion in Q1 2025, and down 5863234.21% on a QoQ basis from $38000.0 in Q4 2025.
Biocryst Pharmaceuticals (BCRX) Retained Earnings (2010 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 17 years of Retained Earnings data on file, last reported at -$2.2 billion in Q1 2026.
- Quarterly Retained Earnings fell 25.87% year-over-year to -$2.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.2 billion (down 25.87% YoY) and the FY2025 annual result came in at $38000.0, up 100.0% from the prior year.
- Retained Earnings fell to -$2.2 billion in Q1 2026, from $38000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $1.3 billion in Q3 2024 to a low of -$2.2 billion in Q1 2026.
- A 5-year average of -$872.1 million and a median of -$1.5 billion in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings soared 654203.95% — and 2023, when it plunged 810827.42%.
- Tracing BCRX's Retained Earnings over 5 years: stood at $1.2 billion in 2022, then slumped by 245.16% to -$1.7 billion in 2023, then declined by 5.29% to -$1.8 billion in 2024, then surged by 100.0% to $38000.0 in 2025, then tumbled by 5863234.21% to -$2.2 billion in 2026.
- The last three Retained Earnings figures came in at -$2.2 billion (Q1 2026), $38000.0 (Q4 2025), and -$1.8 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.11 Bn | 214.41 Mn | -2.15 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.15 Bn |
| Mar 31, 2026 | -2.23 Bn |
| Dec 31, 2025 | 38,000.00 |
| Sep 30, 2025 | -1.75 Bn |
| Jun 30, 2025 | 1.65 Mn |
| Mar 31, 2025 | -1.77 Bn |
| Dec 31, 2024 | -1.77 Bn |
| Sep 30, 2024 | 1.27 Bn |
| Jun 30, 2024 | -1.73 Bn |
| Mar 31, 2024 | -1.72 Bn |
| Dec 31, 2023 | -1.68 Bn |
| Sep 30, 2023 | 1.21 Bn |
| Jun 30, 2023 | -1.58 Bn |
| Mar 31, 2023 | -1.51 Bn |
| Dec 31, 2022 | 1.16 Bn |
| Sep 30, 2022 | -1.38 Bn |
| Jun 30, 2022 | -1.34 Bn |
| Mar 31, 2022 | 186,000.00 |
| Dec 31, 2021 | 177,000.00 |
| Sep 30, 2021 | -1.19 Bn |